Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HekeTiss
AddedFeb 17, 2024
UpdatedJun 18, 2026
HekeTiss

HekeTiss

Angel

HekeTiss SA, a NC-based manufacturer of medical and dental instruments, innovates in wound healing with TrophiPatch.

HQ
Little Switzerland, NC, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

HekeTiss SA, founded as a spin-off from the University Hospitals of Geneva and the University of Geneva, focuses on developing innovative medical solutions for chronic wound healing. Based in Little Switzerland, North Carolina, the company manufactures medical and dental instruments with a core mission to enhance patient care through advanced therapies. Their flagship product, TrophiPatch, is a cellular patch engineered from adipose-derived stem cells that mimics real skin and promotes faster wound healing.

Notable individuals affiliated with HekeTiss include leading researchers from the University of Geneva and University Hospitals of Geneva. The company has attracted significant interest from investors in the medical technology sector due to its groundbreaking approach to chronic ulcer treatment. HekeTiss has achieved recognition for reducing treatment times with TrophiPatch, positively impacting patients suffering from chronic ulcers worldwide.

HekeTiss - Similar Companies

bTECH logo

bTECH

btechls.com

Lotus Tissue Repair logo

Lotus Tissue Repair

RenovoDerm logo

RenovoDerm

WoundForce logo

WoundForce

Biofisica logo

Biofisica

biofisica.com

Newco Wound Care logo

Newco Wound Care

BioTissue logo

BioTissue

biotissue.com

Healogics logo

Healogics

healogics.com

SanaHeal logo

SanaHeal

sanaheal.com

Ulcer Solutions logo

Ulcer Solutions

ulcersolutions.com

Biowound Solutions logo

Biowound Solutions

Histogen logo

Histogen

histogen.com

Wound Care Technologies logo

Wound Care Technologies

Medtric logo

Medtric

medtricbiotech.com

Longhorn Life Sciences logo

Longhorn Life Sciences

HekeTiss - Quick Facts

Who are HekeTiss' competitors?

Companies similar to HekeTiss include bTECH, Lotus Tissue Repair, RenovoDerm and WoundForce.

When was HekeTiss founded?

HekeTiss was founded in 2021.

Where is HekeTiss' headquarters located?

HekeTiss' headquarters is located in Little Switzerland, NC, US.

When was HekeTiss' last funding round?

HekeTiss' most recent funding round was for $50k (USD) in December 2021.

How much has HekeTiss raised to-date?

As of Dec 17, 2021, HekeTiss has raised a total of $50k (USD).

How many employees does HekeTiss have?

HekeTiss has 2 employees as of Feb 4, 2024.

HekeTiss - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
  • Wound Care
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified